Toll-like receptor 4: A potential therapeutic target for multiple human diseases

被引：23
|
作者：
Wei, Jinrui [1 ,2 ,3 ]
Zhang, Yan [1 ,2 ,3 ]
Li, Haopeng [1 ,2 ,3 ]
Wang, Fuquan [1 ,2 ,3 ]
Yao, Shanglong [1 ,2 ,3 ,4 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Inst Anesthesia & Crit Care Med, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Huazhong Univ Sci & Technol, Key Lab Anesthesiol & Resuscitat, Minist Educ, Hongshan, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 166卷
关键词：
Immune response; Toll -like receptor 4; Cardiovascular; Neoplastic; Inflammatory; NF-KAPPA-B; ESOPHAGEAL CANCER-CELLS; TRAUMATIC BRAIN-INJURY; NLRP3; INFLAMMASOME; REGULATORY FACTOR-3; ADHESION MOLECULES; SIGNALING PATHWAYS; ACTIVATION; TLR4; LIPOPOLYSACCHARIDE;
D O I：
10.1016/j.biopha.2023.115338
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The immune response plays a pivotal role in the pathogenesis of diseases. Toll-like receptor 4 (TLR4), as an intrinsic immune receptor, exhibits widespread in vivo expression and its dysregulation significantly contributes to the onset of various diseases, encompassing cardiovascular disorders, neoplastic conditions, and inflammatory ailments. This comprehensive review centers on elucidating the architectural and distributive characteristics of TLR4, its conventional signaling pathways, and its mode of action in diverse disease contexts. Ultimately, this review aims to propose novel avenues and therapeutic targets for clinical intervention.
引用
收藏
页数：9
相关论文
共 50 条
  • [31] Toll-like receptors signaling in glomerular diseases
    Mao, Song
    Huang, Songming
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2014, 34 (02) : 81 - 84
  • [32] Expression and Functional Analysis of Toll-like Receptor 4 in Human Cervical Carcinoma
    Wang, Yongjun
    Weng, Yanjie
    Shi, Ying
    Xia, Xi
    Wang, Shixuan
    Duan, Hua
    JOURNAL OF MEMBRANE BIOLOGY, 2014, 247 (07) : 591 - 599
  • [33] Toll-like receptor signalling and their therapeutic targeting in colorectal cancer
    Moossavi, Shirin
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 16 (02) : 199 - 209
  • [34] Toll-like receptors as therapeutic targets in gastrointestinal diseases
    Pimentel-Nunes, Pedro
    Soares, Joao Bruno
    Roncon-Albuquerque, Roberto, Jr.
    Dinis-Ribeiro, Mario
    Leite-Moreira, Adelino F.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (04) : 347 - 368
  • [35] Computational Approaches to Toll-Like Receptor 4 Modulation
    Billod, Jean-Marc
    Lacetera, Alessandra
    Guzman-Caldentey, Joan
    Martin-Santamaria, Sonsoles
    MOLECULES, 2016, 21 (08)
  • [36] Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin
    Park, Se-Jeong
    Youn, Hyung-Sun
    PHYTOCHEMISTRY, 2010, 71 (14-15) : 1736 - 1740
  • [37] Toll-like Receptor 4 in Acute Kidney Injury
    Valles, Patricia G. G.
    Lorenzo, Andrea Fernanda Gil
    Garcia, Rodrigo D. D.
    Cacciamani, Valeria
    Benardon, Maria Eugenia
    Costantino, Valeria Victoria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [38] The significance of toll-like receptors in human diseases
    Montero Vega, M. T.
    de Andres Martin, A.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2009, 37 (05) : 252 - 263
  • [39] Sam68 is a regulator of Toll-like receptor signaling
    Tomalka, Jeffrey A.
    de Jesus, Tristan J.
    Ramakrishnan, Parameswaran
    CELLULAR & MOLECULAR IMMUNOLOGY, 2017, 14 (01) : 107 - 117
  • [40] Toll and Toll-like receptor signalling in development
    Anthoney, Niki
    Foldi, Istvan
    Hidalgo, Alicia
    DEVELOPMENT, 2018, 145 (09):
12345